These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8260359)

  • 21. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model.
    Langdon SP; Crew AJ; Ritchie AA; Muir M; Wakeling A; Smyth JF; Miller WR
    Eur J Cancer; 1994; 30A(5):682-6. PubMed ID: 8080688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.
    Wiseman LR; Johnson MD; Wakeling AE; Lykkesfeldt AE; May FE; Westley BR
    Eur J Cancer; 1993; 29A(16):2256-64. PubMed ID: 8110496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line.
    Madsen MW; Reiter BE; Lykkesfeldt AE
    Mol Cell Endocrinol; 1995 Apr; 109(2):197-207. PubMed ID: 7664983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
    Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
    Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
    J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone sensitivity in vitro and in vivo of v-ras-transfected MCF-7 cell derivatives.
    Van Roy F; Mareel M; Vleminckx K; Beyaert R; Fiers W; Devleeschouwer N; Muquardt C; Legros N; Bracke M; Leclercq G
    Int J Cancer; 1990 Sep; 46(3):522-32. PubMed ID: 2203690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
    Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
    Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of these cells in vivo.
    Faridi J; Wang L; Endemann G; Roth RA
    Clin Cancer Res; 2003 Aug; 9(8):2933-9. PubMed ID: 12912939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.
    Tonetti DA; Chisamore MJ; Grdina W; Schurz H; Jordan VC
    Br J Cancer; 2000 Sep; 83(6):782-91. PubMed ID: 10952784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
    Gottardis MM; Jiang SY; Jeng MH; Jordan VC
    Cancer Res; 1989 Aug; 49(15):4090-3. PubMed ID: 2743303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated expression of proprotein convertases alters breast cancer cell growth in response to estrogen and tamoxifen.
    Cheng M; Xu N; Iwasiow B; Seidah N; Chrétien M; Shiu RP
    J Mol Endocrinol; 2001 Apr; 26(2):95-105. PubMed ID: 11241161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW; Kurebayashi J; Honig SF; Zwiebel J; Lippman ME; Dickson RB; Kern FG
    Cancer Res; 1993 May; 53(9):2168-77. PubMed ID: 8481920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
    Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.
    Osborne CK; Coronado E; Allred DC; Wiebe V; DeGregorio M
    J Natl Cancer Inst; 1991 Oct; 83(20):1477-82. PubMed ID: 1920493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma].
    Toko T; Saito H; Fujioka A; Nukatuka M; Sato K; Hashimoto A; Shibata J; Yamada Y
    Gan To Kagaku Ryoho; 1998 May; 25(6):829-38. PubMed ID: 9617321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.